Mitotic activity of head neural ganglion cells of Drosophila melanogaster larvae from two genetic stocks was studied. The mutant stock agts3 with augmented activatory potentialities of calmodulin and modified capacity for learning was compared with the control wild type Canton-S stock. The mitotic index was defined as the ratio of the number of cells in the state of division to the total cell number. The mitotic index was calculated after 30-min incubation of the larvae at the temperature of 37 degrees C and without heating under normal conditions (22 degrees C). At 22 degrees C the mitotic index in agts3 was higher than in CS. Exposure to 37 degrees C led to a sharp decrease of mitotic activity in both stocks. Increased mitotic index in agts3 stocks at 22 degrees C was probably connected with augmented activatory potentialities of calmodulin. After preincubation of the neural ganglions with calmodulin inhibitor trifluoperazine (10(-3)M) for 30 minutes the difference between the mutant and control stocks in mitotic index disappeared due to its approximately 3-fold decrease in agts3 stock. The obtained results supported the proposed hypothesis and demonstrated importance of calmodulin as a regulator of mitotic activity of cells from the neural ganglion of Drosophila larvae.
Download full-text PDF |
Source |
---|
Mod Pathol
January 2025
Department of Pathology, Boston Children's Hospital, Boston, MA, 02115 USA. Electronic address:
Soft tissue tumors with smooth muscle differentiation are rare in pediatric patients. Despite often showing morphologic features sufficient for classification as "leiomyosarcoma" in adults (e.g.
View Article and Find Full Text PDFSci Total Environ
January 2025
Laboratório de Análises Genéticas, Departamento de Ciências Naturais e da Terra, Universidade do Estado de Minas Gerais, Divinópolis, MG 35501-170, Brazil. Electronic address:
The rupture of Vale S.A. mining tailings dam in Brumadinho, Brazil, in January 2019 had significant environmental impacts on the Paraopeba River basin.
View Article and Find Full Text PDFFront Biosci (Landmark Ed)
January 2025
The Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Hunan Normal University Health Science Center, 410013 Changsha, Hunan, China.
Background: α thalassemia/mental retardation syndrome X-linked (ATRX) serves as a part of the sucrose nonfermenting 2 (SNF2) chromatin-remodeling complex. In interphase, ATRX localizes to pericentromeric heterochromatin, contributing to DNA double-strand break repair, DNA replication, and telomere maintenance. During mitosis, most ATRX proteins are removed from chromosomal arms, leaving a pool near the centromere region in mammalian cells, which is critical for accurate chromosome congression and sister chromatid cohesion protection.
View Article and Find Full Text PDFPharmaceutics
January 2025
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
: Tamoxifen (TAM) is an anti-breast cancer drug suffering from acquired resistance development, prompting cancer relapse. Propranolol (PRO)'s repurposing for cancer therapy has gained interest. This work aimed to investigate combined TAM/PRO therapy for potentiating the anti-breast cancer activity of TAM.
View Article and Find Full Text PDFPharmaceuticals (Basel)
January 2025
School of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland.
The synthesis of ()-1-(1,3-diphenylallyl)-1-1,2,4-triazoles and related compounds as anti-mitotic agents with activity in breast cancer was investigated. These compounds were designed as hybrids of the microtubule-targeting chalcones, indanones, and the aromatase inhibitor letrozole. : A panel of 29 compounds was synthesized and examined by a preliminary screening in estrogen receptor (ER) and progesterone receptor (PR)-positive MCF-7 breast cancer cells together with cell cycle analysis and tubulin polymerization inhibition.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!